High Quality Rimonabant CAS 168273-06-1 for Fat Loss Weight Loss

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Frazer-Rimonabant
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: White Powder
• Purity: >99%
• Grade: Pharmaceutical Grade
• Appearance: White Powder
• CAS No: 168273-06-1
• Shelf Life: 2 Years
• Test Method: HPLC
• Form: Powder
• Storage: Store Cool Dry Place
• MW: 463.79
• Melting Point: 256-257°c
• Transport Package: Foil Bag
• Specification: 99%
• Trademark: Xi′an Frazer Biotech Co., Ltd.
• Origin: China
• Production Capacity: 2000kg/Month

Product Description

High Quality Rimonabant CAS 168273-06-1 for Fat Loss Weight Loss

Description:

Rimonabant is a weight loss drug, can significantly reduce weight, reduce waist circumference and reduce risk factors for cardiovascular disease, but also can improve blood lipids and resistance and metabolic syndrome, especially for the presence of clinical obesity or heart disease people at risk.
Rimonabant as a new weight loss drug, can also be used to quit smoking. Not only lose weight,but also lower blood pressure, cholesterol and blood sugar, clinical study found that subjects taking one to two months later, the weight can be reduced on average six to eight kilograms.

Application

1) Obesity

In a 2006 (2 year) study reported in JAMA, "Compared with the placebo group, the 20 mg of rimonabant group produced greater mean (SEM) reductions in weight (-6.3 [0.2] kg vs -1.6 [0.2] kg; P<.001), waist circumference (-6.1 [0.2] cm vs -2.5 [0.3] cm; P<.001), and level of triglycerides (percentage change, -5.3 [1.2] vs 7.9 [2.0]; P<.001) and a greater increase in level of high-density lipoprotein cholesterol (percentage change, 12.6 [0.5] vs 5.4 [0.7]; P<.001)." [12]

2) Smoking cessation

Rimonabant may also be found to be effective in assisting some smokers to quit smoking. Sanofi is currently conducting studies to determine the possible value of rimonabant in smoking-cessation therapy. The Studies with Rimonabant and Tobacco Use (STRATUS) program involves more than 6,000 subjects.

Stratus is designed to explore two smoking-related therapies: first, to use rimonabant directly to aid in smoking cessation; second, to help prevent weight gain in former smokers. Initial results apparently suggest rimonabant is effective for both uses. However, the FDA has explicitly stated to Sanofi that, without additional studies, rimonabant cannot be approved in the United States for smoking cessation therapy.

Specifications :

Test Items	Specification	Test Results
Appearance	White to off white powder	Complies
Odor and taste	Odorless	Complies
Identification	Positive reaction	Complies
Mesh size	100% pass 80 mesh	Complies
Melting Point	272.25ºC	Complies
Loss on drying	1%Max	0.78%
Water	≤2.0%	0.1%
Residue on ignition	0.1%Max	Complies
Single impurity	0.1%Max	Complies
Boiling point	627.69ºC	Complies
PH	5.0~70.	6.5
Solubility	Soluble in ethanol(-20 mg/ml). DMSO(25 mg/ml). DMF(-20 mg/ml) and water (<1 mg/ml)	Complies
Heavy metals	NMT 10ppm	Complies
Assay(HPLC)	99%~101%	99.43%
Microbiological control
Total plate count Fungi Salmonella Coli	1000 cfu/g Max <100/g 78 cfu/g	Negative
Shelf life	2 years when properly stored